Cleared Traditional

K101552 - FOSHAN CARE MEDICAL NEBULIZER MODEL KYWH2001

K101552 is an FDA 510(k) clearance for FOSHAN CARE MEDICAL NEBULIZER MODEL KYW..., manufactured by Foshan Care Medical Technology Co., Ltd.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 283-day FDA review.

K101552 · Foshan Care Medical Technology Co., Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2011
Decision
283d
Days
Class 2
Risk

K101552 is an FDA 510(k) clearance for the FOSHAN CARE MEDICAL NEBULIZER MODEL KYWH2001. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Foshan Care Medical Technology Co., Ltd. (Carmichael, US). The FDA issued a Cleared decision on March 14, 2011 after a review of 283 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Foshan Care Medical Technology Co., Ltd. devices

FDA 510(k) Submission Details - K101552

510(k) Number K101552 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 2010
Decision Date March 14, 2011
Days to Decision 283 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
143d slower than avg
Panel avg: 140d · This submission: 283d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 407
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K101552.
ATLANTEAN TRIGGER NEBULIZER
K102719 · Atlantean Corporation · Jul 2011
AEROVENT PLUS CHC
K110273 · Monaghan Medical Corporation · Jun 2011
CONTINUOUS NEBULIZATION TUBE SET (CNTS) TUBING: AG-AS3075 + SYRINGE: AG-AS3085
K103635 · Aerogen, Ltd. · May 2011
SMDIA-1000
K101953 · Southmedic, Inc. · Jan 2011
MINISPACER DUAL-SPRAY MDI ADAPTER WITH 22MM (OR 15MM) OD / 22MM OD/ID CONNECTIONS / 15MM ID CONNECTIONS
K102658 · Thayer Medical Corp. · Dec 2010
NIVO NEBULIZER SYSTEM
K102240 · Aerogen (Ireland), Ltd. · Nov 2010